Yue Y - Search Results

1

IL-33/ST2 as a potential target for tumor immunotherapy.

Jiang W, Lian J, Yue Y, Zhang Y. Jiang W, et al. Among authors: yue y. Eur J Immunol. 2021 Aug;51(8):1943-1955. doi: 10.1002/eji.202149175. Epub 2021 Jun 23. Eur J Immunol. 2021. PMID: 34131922 Free article. Review.

2

Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling.

Yue Y, Song M, Qiao Y, Li P, Yuan Y, Lian J, Wang S, Zhang Y. Yue Y, et al. Oncotarget. 2017 Oct 30;8(62):105222-105237. doi: 10.18632/oncotarget.22160. eCollection 2017 Dec 1. Oncotarget. 2017. PMID: 29285246 Free PMC article.

3

The R132H mutation in IDH1 promotes the recruitment of NK cells through CX3CL1/CX3CR1 chemotaxis and is correlated with a better prognosis in gliomas.

Ren F, Zhao Q, Huang L, Zheng Y, Li L, He Q, Zhang C, Li F, Maimela NR, Sun Z, Jia Q, Ping Y, Zhang Z, Chen X, Yue Y, Liu S, Cao L, Zhang Y. Ren F, et al. Among authors: yue y. Immunol Cell Biol. 2019 May;97(5):457-469. doi: 10.1111/imcb.12225. Epub 2019 Jan 25. Immunol Cell Biol. 2019. PMID: 30575118

4

The repertoire features of T cell receptor β-chain of different age and gender groups in healthy Chinese individuals.

Lian J, Liu J, Yue Y, Li F, Chen X, Zhang Z, Ping Y, Qin G, Li L, Zhang K, Liu S, Zhang L, Qiao S, Liu N, Zheng Y, Wu J, Zeng Q, Zhang Y. Lian J, et al. Among authors: yue y. Immunol Lett. 2019 Apr;208:44-51. doi: 10.1016/j.imlet.2019.03.007. Epub 2019 Mar 21. Immunol Lett. 2019. PMID: 30905825

5

Interleukin-33-nuclear factor-κB-CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells.

Yue Y, Lian J, Wang T, Luo C, Yuan Y, Qin G, Zhang B, Zhang Y. Yue Y, et al. Cancer Sci. 2020 Mar;111(3):795-806. doi: 10.1111/cas.14293. Epub 2020 Feb 15. Cancer Sci. 2020. PMID: 31883400 Free PMC article.

6

Correction: Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling.

Yue Y, Song M, Qiao Y, Li P, Yuan Y, Lian J, Wang S, Zhang Y. Yue Y, et al. Oncotarget. 2020 Mar 3;11(9):891-892. doi: 10.18632/oncotarget.27371. eCollection 2020 Mar 3. Oncotarget. 2020. PMID: 32180901 Free PMC article.

7

Eomes promotes esophageal carcinoma progression by recruiting Treg cells through the CCL20-CCR6 pathway.

Lian J, Liu S, Yue Y, Yang Q, Zhang Z, Yang S, Zhang Y. Lian J, et al. Among authors: yue y. Cancer Sci. 2021 Jan;112(1):144-154. doi: 10.1111/cas.14712. Epub 2020 Nov 17. Cancer Sci. 2021. PMID: 33113266 Free PMC article.

8

Immunosenescence: a key player in cancer development.

Lian J, Yue Y, Yu W, Zhang Y. Lian J, et al. Among authors: yue y. J Hematol Oncol. 2020 Nov 10;13(1):151. doi: 10.1186/s13045-020-00986-z. J Hematol Oncol. 2020. PMID: 33168037 Free PMC article. Review.

9

Molecular mechanism study of HGF/c-MET pathway activation and immune regulation for a tumor diagnosis model.

Shen Z, Xue W, Zheng Y, Geng Q, Wang L, Fan Z, Wang W, Yue Y, Zhai Y, Li L, Zhao J. Shen Z, et al. Among authors: yue y. Cancer Cell Int. 2021 Jul 14;21(1):374. doi: 10.1186/s12935-021-02051-2. Cancer Cell Int. 2021. PMID: 34261467 Free PMC article.

10

Integrated analysis profiles of long non-coding RNAs reveal potential biomarkers of drug resistance in lung cancer.

Xue W, Li L, Tian X, Fan Z, Yue Y, Zhang C, Ding X, Song X, Ma B, Zhai Y, Lu J, Kan Q, Zhao J. Xue W, et al. Among authors: yue y. Oncotarget. 2017 Mar 22;8(38):62868-62879. doi: 10.18632/oncotarget.16444. eCollection 2017 Sep 8. Oncotarget. 2017. PMID: 28968955 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,472 results

Search Page